| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 626878 | Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride | 0.00479683626511385 | 0.22294354 |
| NSC 628115 | 9-N(N'-chloroethyl-N'-methyl-1,2-diaminoethyl) 2 methoxyacridine dihydrochloride | 0.00479683626511385 | 0.58078495 |
| NSC 638435 | Null | 0.00479683626511385 | 0.40738323 |
| NSC 672472 | Null | 0.00479683626511385 | 0.31426626 |
| NSC 681637 | Camptothecin Derivative | 0.00479683626511385 | 0.39192213 |
| NSC 702015 | 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- | 0.00479683626511385 | 0.11817987 |
| NSC 756169 | GSK317314A | 0.00479683626511385 | 0.26060647 |
| NSC 146268 | as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- | 0.00645628049634952 | 0.64609995 |
| NSC 201459 | 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- | 0.00645628049634952 | 0.29378161 |
| NSC 295426 | Propanoic acid, 2-methyl-, 2,3,3a,4,5,8,9,11a-octahydro-6,10-bis(hydroxymethyl)-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, [3aR-(3aR*,4S*,6Z,10Z,11aR*)]- (9CI) | 0.00645628049634952 | 0.10432427 |